ClinicalTrials.gg
Not yet recruitingNCT07261384TIP-MIGUpdated Dec 3, 2025

"Personalized Physiotherapy for Migraine: Effects on Pain, Fatigue, and Physical Function"

An interventional study of Personalized Structured Physiotherapy Intervention and Standard Treatment in Migraine, sponsored by Hacettepe University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-12-03.

Sponsored by Hacettepe University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 92 studies in Migraine Disorders with a site in Turkey — 20 open to participants now, 25 under way, 3 of them phase 3. Migraine Disorders · Turkey.

Planned enrollment
47th of 69
50 · median 73
Started
2025
with 13 others
No phase
56 of 92
13 open now
Primary completion
2027-01
later than 20 of 24 live
Registered
79th of 92
by date
Lead sponsor
5 of 92
Hacettepe University

Among the 92 studies in Migraine Disorders with a site in Turkey, this one is the 47th largest by planned enrollment of the 69 interventional ones that give a count, is one of 14 that started in 2025, is one of 56 with no phase, reaches primary completion later than 20 of the 24 other live ones, and was the 79th registered.

Migraine Disorders

1,660 studies on the registry are indexed under Migraine Disorders; 340 are open to participants now.

Browse Migraine Disorders studies →

Open to participants now

20 of the 92 studies in Migraine Disorders with a site in Turkey are open now. Recruiting first, the newest first:

14 more — sign in →

All 20 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 217 Migraine Disorders studies recruiting now, 66 (30%) set no upper age limit and 136 (63%) stop at 75 or younger; 44 take children under 18; 37 take healthy volunteers.

This study: 18 Years to 55 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 92 studies in Migraine Disorders with a site in Turkey, or all of them as a file.
02

Study summary

Migraine is a prevalent neurological disorder associated with pain, fatigue, and reduced physical function. The aim of this randomized controlled trial is to examine the effects of a personalized and structured physiotherapy program-including cervical spine stabilization exercises, vestibular rehabilitation, and pain neuroscience education-on pain intensity, fatigue, and functional outcomes in individuals with migraine. Participants will be randomly allocated to an intervention group receiving personalized physiotherapy or a control group receiving standard physiotherapy care. Outcomes will be assessed at baseline, post-intervention, and follow-up.

Read the detailed description

Migraine is a disabling primary headache disorder characterized by recurrent attacks and frequently accompanied by cervical musculoskeletal dysfunction, vestibular symptoms, and altered pain processing mechanisms. Current evidence suggests that physiotherapy interventions targeting manual therapy, cervical stabilization, vestibular function, and pain neuroscience education may positively influence migration-related outcomes; However, studies combining these components in a personalized treatment model are limited.

This randomized controlled trial aims to investigate the effectiveness of a personalized structured physiotherapy program designed specifically for individuals with migraine. The interventions will include manual therapy, cervical spine stabilization exercises, vestibular rehabilitation strategies, and pain neuroscience education delivered by a physiotherapist. The control group will receive only pain neuroscience education.

Primary outcomes will include pain intensity and frequency. Secondary outcomes will include fatigue, disability level, cervical function, physical performance, and patient-reported functional limitations. Assessments will be conducted at baseline, immediately post-intervention, and during a follow-up period. The findings are expected to contribute to evidence-based physiotherapy approaches for migraine management.

03

Conditions studied

  • Migraine

Keywords

  • Migraine
  • Fatigue
  • Pain
  • Physical Function
  • Individualized Physical Therapy
04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 and 55 years

    • Diagnosed with migraine according to the International Classification of Headache Disorders - 3rd edition (ICHD-3) criteria
    • Experiencing 2-8 migraine attacks per month in the last 3 months
    • Able to participate in an 8-week physiotherapy intervention program
    • Able to understand instructions and provide written
    • Stable medication use for migraine for at least 1 month prior to participation (no changes planned during study period)

Exclusion criteria

Exclusion Criteria:

    • Presence of other primary headache disorders (cluster headache, tension-type headache as primary diagnosis, etc.)

      • Neurological diseases (epilepsy, stroke, multiple sclerosis)
      • Vestibular disorders unrelated to migraine
      • Cervical radiculopathy, myelopathy, or severe cervical spine pathology
      • History of neck surgery or significant cervical trauma
      • Severe musculoskeletal conditions affecting posture or cervical function
      • Pregnancy or breastfeeding
      • Participation in another clinical trial within the last 3 months
      • Inability to attend intervention sessions or complete outcome assessments
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Personalized Structured Physiotherapy Intervention

    Participants will receive a personalized, structured physiotherapy program including manual therapy, cervical spine stabilization exercises, vestibular rehabilitation exercises, and pain neuroscience education. The intervention will be delivered by a licensed physiotherapist twice weekly for 8 weeks. The manual therapy will include component, applied according to individual patient needs to reduce pain, improve mobility, and modulate neuromuscular control. The cervical spine stabilization exercises will target deep neck flexors and cervical postural muscles to improve neuromuscular control, endurance, and motor coordination. The vestibular rehabilitation component will include gaze stabilization, habituation, and balance exercises tailored to migraine-related vestibular symptoms. The PNE program will consist of structured individual education sessions focusing on pain neurobiology, central sensitization, and self-management strategies. Participants will attend supervised physio

    Other: Personalized Structured Physiotherapy Intervention

  • Active comparator
    Standard Treatment

    Participants will continue their routine migraine care, including any pharmacological treatment. During the 8-week study period, they will receive only two 40-minute Pain Neuroscience Education sessions. No additional physiotherapy or exercise interventions.

    Other: Standard Treatment

Interventions

  • OtherPersonalized Structured Physiotherapy Intervention

    The manual therapy will include component, applied according to individual patient needs to reduce pain, improve mobility, and modulate neuromuscular control. The cervical spine stabilization exercises will target deep neck flexors and cervical postural muscles to improve neuromuscular control, endurance, and motor coordination. The vestibular rehabilitation component will include gaze stabilization, habituation, and balance exercises tailored to migraine-related vestibular symptoms. The PNE program will consist of structured individual education sessions focusing on pain neurobiology, central sensitization, and self-management strategies. Participants will attend supervised physiotherapy sessions twice weekly for 8 weeks, complemented by a personalized home exercise program. All components will be delivered by a licensed physiotherapist.

  • OtherStandard Treatment

    Participants continue routine care including medications prescribed by their physician. Only two 40-minute Pain Neuroscience Education sessions over 8 weeks. No physiotherapy or exercise intervention provided.

06

What researchers measure

Primary outcomes

  1. Pain Intensity (VAS)

    Pain intensity will be assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Measurements will be taken at baseline, and at the completion of the 8-week intervention.

    Time frame: Baseline, Week 8

Secondary outcomes

  1. Pain Frequency (MIDAS A Question)

    Pain frequency will be assessed using Question A of the Migraine Disability Assessment Questionnaire (MIDAS), which evaluates the number of headache days over the previous 3 months.

    Time frame: Baseline and Week 8

  2. Fatigue (Modified Fatigue Impact Scale - MFIS)

    Fatigue levels will be measured using the Modified Fatigue Impact Scale (MFIS), which evaluates physical, cognitive, and psychosocial aspects of fatigue.

    Time frame: Baseline and Week 8

  3. Migraine Disability (MIDAS Total Score)

    Migraine-related disability will be assessed with the MIDAS total score, which quantifies the impact of migraine on daily activities over the past 3 months.

    Time frame: Baseline and Week 8

  4. Quality of Life (Headache Impact Test - HIT-6)

    Quality of life will be evaluated using the HIT-6 questionnaire, which measures headache-related impact on daily functioning.

    Time frame: Baseline and Week 8

  5. Craniovertebral Angle (Forward Head Posture)

    Forward head posture will be assessed by measuring the craniovertebral angle using a goniometer, with smaller angles indicating more pronounced forward head posture.

    Time frame: Baseline and Week 8

  6. Cervical Range of Motion

    Cervical mobility (flexion, extension, lateral flexion, rotation) will be measured with a goniometer to assess changes in cervical spine range of motion.

    Time frame: Baseline and Week 8

  7. Deep Cervical Flexor Muscle Performance

    Deep cervical flexor endurance and activation will be assessed using the Stabilizer Pressure Biofeedback Unit during cranio-cervical flexion tasks.

    Time frame: Baseline and Week 8

  8. Trigger Point Tenderness / Pressure Pain Threshold

    Assessment with Manuel compression.

    Time frame: Baseline and Week 8

  9. Neck Pain Intensity (VAS)

    Neck pain intensity will be measured using a 0-10 Visual Analog Scale (VAS) to assess changes over time.

    Time frame: Baseline, Week 8

  10. Dizziness Handicap (DHI)

    Vestibular disability will be assessed with the Dizziness Handicap Inventory (DHI), evaluating functional, emotional, and physical impacts of dizziness.

    Time frame: Baseline and Week 8

  11. Balance (Mini-BESTest)

    Balance performance will be evaluated using the Mini-Balance Evaluation Systems Test (Mini-BESTest), which assesses dynamic balance and postural control.

    Time frame: Baseline and Week 8

07

Study locations

1 site
  • Erzincan Binali Yıldırım Univercity, Medicine Faculty
    Erzincan, 24000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared. The dataset contains sensitive clinical information, and sharing is not planned. Only aggregated results will be available upon publication.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2025; primary completion for Jan 2027, 13 months later.

Of 310 non-industry interventional studies with no phase under Migraine Disorders, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 13 months is below that.

Counting every sponsor, half of 360 studies reached it within 15 months; a quarter within 7 and three quarters within 33.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 22, 2025
First posted
Dec 3, 2025
StartEst.
Dec 1, 2025
Primary completionEst.
Jan 30, 2027
CompletionEst.
Jan 30, 2028
Last update
Dec 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07261384
Responsible party
Ikra Hatice Dinc (Principal Investigator, Hacettepe University) — Principal investigator
First posted
Dec 3, 2025
Start date
Dec 1, 2025 (estimated)
Primary completion
Jan 30, 2027 (estimated)
Completion
Jan 30, 2028 (estimated)
Last update
Dec 3, 2025

Study contacts

İkra Hatice DİNÇ, MSC
Contact
ikrahatice1997@gmail.com
+905374115611
Yeliz SALCI, Associate Professor
Contact
fztyeliz@hotmail.com
+905303272310

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion